Recombinant Human Bone Morphogenetic Protein-2 Use in Adult Spinal Deformity Surgery: Comparative Analysis and Healthcare Utilization at 24 Months' Follow-up.

Global Spine J · 2022 · PMC8965293 · PMID 32844671

Europe PMC DOI

hedged sentence

0.0558

closest p · 1.1× alpha

0.0558

boldest claim

The sentences

a nonsignificant trendP = .0558so close (0.05 < p ≤ 0.1)

One month after discharge, the rhBMP-2 cohort had a nonsignificant trend in fewer complications (15.38%) than those who did not receive rhBMP-2 (18.07%), P = .0558.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.